Articles by Patricia Van Arnum - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

  • Search
  • Suppliers
  • Careers

Enter a company or product name

Keyword Location
About Search
Articles by Patricia Van Arnum

Pfizer Issued Warning Letter for Italian Manufacturing Plant

Company is notified of GMP violations at facility in Catania, Italy.
Apr 11, 2013

Company is notified of GMP violations at facility in Catania, Italy.

Navigating the Global Manufacturing Supply Chain

As the strategic value of emerging markets increase, pharmaceutical companies increase their R&D and manufacturing investments.
Apr 10, 2013

As the strategic value of emerging markets increase, pharmaceutical companies increase their R&D and manufacturing investments.

Eli Lilly Considers Investment in US Insulin-Manufacturing Capacity

Company considers investment in insulin cartridge-filling and insulin API manufacturing capacity in the US.
Apr 8, 2013

Company considers investment in insulin cartridge-filling and insulin API manufacturing capacity in the US.

Pfizer Voluntarily Recalls Levoxyl

Company issues voluntary recall after learning of complaints of an uncharacteristic odor coming from Levoxyl bottles.
Apr 8, 2013

Company issues voluntary recall after learning of complaints of an uncharacteristic odor coming from Levoxyl bottles.

GlaxoSmithKline Tops Industry Rankings for Access to Medicines

The Access to Medicines Index shows that pharmaceutical companies are increasing drug development for the developing world and using more tiered pricing mechanisms to lower pricing.
Apr 3, 2013

The Access to Medicines Index shows that pharmaceutical companies are increasing drug development for the developing world and using more tiered pricing mechanisms to lower pricing.

The Plan by AstraZeneca CEO Pascal Soriot to Revitalize the Company

Restructuring and a strategic focus on three hubs in research and development are part of a plan to restart growth.
Apr 3, 2013

Restructuring and a strategic focus on three hubs in research and development are part of a plan to restart growth.

Indian Supreme Court Rejects Patent for Glivec by Novartis

Ruling has implications for intellectual property protection for innovator drugs in India.
Apr 3, 2013

Ruling has implications for intellectual property protection for innovator drugs in India.

Novartis Suffers Setback in Indian Patent Case for Glivec

Apr 2, 2013

Novartis loses an appeal in seeking patent protection in India for its anticancer drug.

Fine-Chemical Producers Make Targeted Investments

Contract API manufacturers proceed with select investment in capacity and service additions.
Apr 2, 2013

Contract API manufacturers proceed with select investment in capacity and service additions.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
35%
Breakthrough designations
12%
Protecting the supply chain
35%
Expedited reviews of drug submissions
12%
More stakeholder involvement
6%
View Results
Jim Miller Outsourcing Outlook Jim Miller Health Systems Raise the Bar on Reimbursing New Drugs
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerThe Mainstreaming of Continuous Flow API Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler Industry Seeks Clearer Standards for Track and Trace
Siegfried Schmitt Ask the Expert Siegfried SchmittData Integrity
FindPharma Custom Search
Click here